Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Oncol. May 10, 2011; 2(5): 229-236
Published online May 10, 2011. doi: 10.5306/wjco.v2.i5.229
Published online May 10, 2011. doi: 10.5306/wjco.v2.i5.229
FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations
Koji Murakami, Division of Nuclear Medicine, Department of Radiology , School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku-ku, 160-8582 Tokyo, Japan
Author contributions: Murakami K solely contributed to this paper.
Correspondence to: Koji Murakami, Professor, Division of Nuclear Medicine, Department of Radiology , School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku-ku, 160-8582 Tokyo, Japan. kjmuraka@z3.keio.jp
Telephone: +81-3-33531211-64446 Fax: +81-3-33531977
Received: January 24, 2011
Revised: March 8, 2011
Accepted: March 15, 2011
Published online: May 10, 2011
Revised: March 8, 2011
Accepted: March 15, 2011
Published online: May 10, 2011
Core Tip